Bristol Myers Squibb Stock Earns 83 RS Rating

Blockhead

2024-12-20

On Thursday, Bristol Myers Squibb (BMY) stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.

↑ X

This Is How A New President Will Impact Fed Rate Cuts In 2025

See All Videos

NOW PLAYING This Is How A New President Will Impact Fed Rate Cuts In 2025

IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.

Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves.

Looking For The Best Stocks To Buy And Watch? Start Here

Is Bristol Myers Squibb A Buy?

Bristol Myers Squibb stock is building a with a 61.08 entry. See if it can break out in heavy trading. Read "Looking For The Next Big Stock Market Winners? Start With These 3 Steps" for more tips.

The drug maker posted -10% earnings growth in its most recent report. Sales rose 8%.

Bristol Myers Squibb stock earns the No. 3 rank among its peers in the Medical-Ethical Drugs industry group. Phibro Animal Health (PAHC) is the top-ranked stock within the group. For more industry news, check out "Biotech And Pharmaceutical Industry And Stock News."

YOU MAY ALSO LIKE:

Learn How To Time The Market With IBD's ETF Market Strategy

Find Today's Best Growth Stocks To Watch With IBD 50

Find The Best Long-Term Investments With IBD Long-Term Leaders

How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2492489093"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2492489093\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2492489093?lang=zh_CN&edition=fundamental","thumbnail":"https://www.investors.com/wp-content/uploads/2017/05/IRU4-150x150.jpg","is_english":true,"pubTime":"2024-12-20 03:28","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2492489093","market":"nz","top_or_hot":-1,"title":"Bristol Myers Squibb Stock Earns 83 RS Rating","media":"Blockhead","content":"<html><body><div>\n<p>On Thursday, <b>Bristol Myers Squibb</b> (BMY) stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.</p>\n<span>\n<span>\n<span jw-video-key=\"ULpM3j8K\" vid-authors=\"MEREDITH HEYMAN\" vid-cat=\"IBD Explains\" vid-date=\"12/17/2024\" vid-date-tmsp=\"1734424574\" vid-dom-id=\"9579501-6764898e36fb9\" vid-id=\"9579501\" vid-image=\"https://www.investors.com/wp-content/uploads/2024/12/ULpM3j8K-640x360.jpg\" vid-name=\"This Is How A New President Will Impact Fed Rate Cuts In 2025\" vid-repeat=\"1\" vid-top=\"\" vid-url=\"https://content.jwplatform.com/manifests/ULpM3j8K.m3u8\" vid-width=\"50\">\n<span>↑</span>\n<span>X</span>\n<span>\n<span></span>\n<div>\n<div>\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n</div>\n<div>\nSee All Videos\n</div>\n</div>\n</span>\n<span>\n<span>NOW PLAYING</span>\n<span>This Is How A New President Will Impact Fed Rate Cuts In 2025</span>\n</span>\n</span>\n</span>\n</span>\n<p>IBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.</p>\n<p>Over 100 years of market history shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves.</p>\n<hr/>\n<p>Looking For The Best Stocks To Buy And Watch? Start Here</p>\n<hr/>\n<h2>Is Bristol Myers Squibb A Buy?</h2>\n<p>Bristol Myers Squibb stock is building a with a 61.08 entry. See if it can break out in heavy trading. <span>Read \"</span><span>Looking For The Next Big Stock Market Winners? Start With These 3 Steps</span><span>\" for more tips.</span></p>\n<div><div></div></div>\n<p>The drug maker posted -10% earnings growth in its most recent report. Sales rose 8%.</p>\n<p>Bristol Myers Squibb stock earns the No. 3 rank among its peers in the Medical-Ethical Drugs industry group. <b>Phibro Animal Health</b> (PAHC) is the top-ranked stock within the group. For more industry news, check out \"Biotech And Pharmaceutical Industry And Stock News.\"</p>\n<p><strong>YOU MAY ALSO LIKE:</strong></p>\n<p><span>Learn How To Time The Market With IBD's ETF Market Strategy</span></p>\n<p><span>Find Today's Best Growth Stocks To Watch With IBD 50</span></p>\n<p><span>Find The Best Long-Term Investments With IBD Long-Term Leaders</span></p>\n<p><span>How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks</span></p>\n</div></body></html>","source":"investor_business_daily_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bristol Myers Squibb Stock Earns 83 RS Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBristol Myers Squibb Stock Earns 83 RS Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-20 03:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/bristol-myers-squibb-stock-earns-83-rs-rating/><strong>Blockhead</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On Thursday, Bristol Myers Squibb (BMY) stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.\n\n\n\n↑\nX\n\n\n\n\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n\n\n...</p>\n\n<a href=\"https://www.investors.com/news/bristol-myers-squibb-stock-earns-83-rs-rating/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RS","symbol_name":"Reliance Steel & Aluminum Co","start_time":0,"source_url":"https://www.investors.com/news/bristol-myers-squibb-stock-earns-83-rs-rating/","article_id":"2492489093","we_media_id":null,"thumbnails":["https://www.investors.com/wp-content/uploads/2017/05/IRU4-150x150.jpg"],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2492489093","pubTimestamp":1734636480,"columns":[],"sourceInfo":{"source_id":"investor_business_daily_highlight","name":"Investor’s Business Daily"},"weMediaInfo":null,"summary":"Bristol Myers Squibb sees its Relative Strength Rating reach the 80-plus level.","collect":0,"end_time":0,"defaultTopTitle":"investors.com","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"RS":"Reliance Steel & Aluminum Co","BMY":"施贵宝","MYE":"Myers Industries Inc"},"translate_title":"百时美施贵宝股票获得83卢比评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMY":1,"MYE":1,"RS":1},"content_text":"On Thursday, Bristol Myers Squibb (BMY) stock got a positive adjustment to its Relative Strength (RS) Rating, from 80 to 83.\n\n\n\n↑\nX\n\n\n\n\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n\n\nSee All Videos\n\n\n\n\nNOW PLAYING\nThis Is How A New President Will Impact Fed Rate Cuts In 2025\n\n\n\n\nIBD's proprietary rating tracks price performance with a 1 (worst) to 99 (best) score. The score shows how a stock's price behavior over the trailing 52 weeks stacks up against all the other stocks in our database.\nOver 100 years of market history shows that the stocks that go on to make the biggest gains typically have an RS Rating north of 80 in the early stages of their moves.\n\nLooking For The Best Stocks To Buy And Watch? Start Here\n\nIs Bristol Myers Squibb A Buy?\nBristol Myers Squibb stock is building a with a 61.08 entry. See if it can break out in heavy trading. Read \"Looking For The Next Big Stock Market Winners? Start With These 3 Steps\" for more tips.\n\nThe drug maker posted -10% earnings growth in its most recent report. Sales rose 8%.\nBristol Myers Squibb stock earns the No. 3 rank among its peers in the Medical-Ethical Drugs industry group. Phibro Animal Health (PAHC) is the top-ranked stock within the group. For more industry news, check out \"Biotech And Pharmaceutical Industry And Stock News.\"\nYOU MAY ALSO LIKE:\nLearn How To Time The Market With IBD's ETF Market Strategy\nFind Today's Best Growth Stocks To Watch With IBD 50\nFind The Best Long-Term Investments With IBD Long-Term Leaders\nHow To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"}}}